SURE CHECK® HIV 1/ 2 Assay
Product Information
By the end of 2005 there were approximately 40.3 million people living with HIV/AIDS including 17.5 million women and 2.3 million children under the age of 15. Nearly 5 million people were newly infected with HIV/AIDS. In the same year, 3.1 million people died of HIV/AIDS-related causes. HIV/AIDS is caused by infection with Human Immunodeficiency Virus, HIV 1 or HIV 2. HIV 1 is the most frequently found strain worldwide. Infection with HIV 2 is foundprimarily in West Africa, although infections have been identified in other areas of the world.
HIV is spread by sexual contact with an infected person, by sharing needles and/or syringes (primarily for drug injection) with someone who is infected, or, less commonly (and now very rarely in countries where blood is screened for HIV antibodies), throughtransfusions of infected blood or blood clotting factors. Babies born to HIV infected women may become infected before or during birth or through breast-feeding after birth. Patients with HIV/AIDS and HIV/AIDS related diseases usually have a high level of the antibody to the viruses.
 The standard screening test for antibodies to HIV is the enzyme immunoassay (EIA) or ELISA which is widely used in the United States and around the world. This test requires two visits to a clinic or medical facility; one to receive pretest counseling and to have blood drawn for HIV testing, and the second to receive test results and additional counseling and if needed referrals. Rapid, point-of-care (POC) tests have been developed which produce results within 20 minutes or less and allows testing, counseling and referrals to be accomplished in one visit. Rapid tests are less costly for testing agencies to perform due to the fewer outreach visits required to deliver results. Patients receive counseling, test results and referrals (if warranted) in one visit. Also, studies have shown that rapid tests are as sensitive and specific as conventional immunoassays.
Chembio Diagnostic Systems, Inc.’s SURE CHECK® HIV 1 / 2, HIV 1/ 2 STAT-PAK® and HIV 1/ 2 STAT-PAK® Dipstick tests are easy-to-perform, single-use diagnostic tests for the rapid, visual detection of antibodies to HIV 1 and HIV 2.
Assay Features
Convenient & Cost Effective
- Ideally suited for field and point-of-care testing
- Minimal sample size required—2.5 fingerstick or venous whole blood, serum or plasma
- Room temperature storage
- Long shelf life
- No special laboratory equipment required
Time & Labor Saving
- Ready-to-Use Reagents
- Simple procedure
- Total test time < 15 minutes
- Results are easy to interpret
Reliable Results
- Built-in IgG procedural control
- Highly sensitive and specific
|
